Mannkind (MNKD) Invested Capital (2013 - 2026)
Mannkind (MNKD) posted quarterly Invested Capital of $23.9 million for Q1 2026, up 12.99% quarter-over-quarter from $21.1 million in Q4 2025.
Mannkind (MNKD) Invested Capital (2013 - 2026) Analysis & Trends
Mannkind (MNKD) has reported Invested Capital for 13 consecutive years, with $23.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Invested Capital changed N/A year-over-year to $23.9 million; the TTM figure through Mar 2026 stood at $45.0 million (changed N/A YoY), while the FY2025 annual figure was $21.1 million, changed N/A from the prior year.
- Invested Capital rose to $23.9 million in Q1 2026 per MNKD's latest filing, from $21.1 million in the prior quarter.
- Across five years, Invested Capital topped out at $104.1 million in Q4 2022 and bottomed at $21.1 million in Q4 2025.
- Historically, Invested Capital has averaged $89.1 million across 5 years, with a median of $104.0 million in 2022.
- Annual changes were most pronounced in 2022 — Invested Capital gained 3.58% — and 2023, when it changed 0.0%.
- Mannkind's Invested Capital stood at $104.1 million in 2022, then changed by 0.0% to $104.1 million in 2023, then changed by 0.0% to $104.1 million in 2024, then tumbled by 79.7% to $21.1 million in 2025, then grew by 12.99% to $23.9 million in 2026.
- Business Quant data shows MNKD's Invested Capital at $23.9 million in Q1 2026, $21.1 million in Q4 2025, and $104.1 million in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 190.90 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.57 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 380.00 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Mannkind | 1.19 Bn | 1.08 Bn | 94.97 Mn | 34.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 34.02 Mn |
| Mar 31, 2026 | 23.88 Mn |
| Dec 31, 2025 | 21.13 Mn |
| Mar 31, 2024 | 104.10 Mn |
| Dec 31, 2023 | 104.10 Mn |
| Sep 30, 2023 | 104.10 Mn |
| Jun 30, 2023 | 104.10 Mn |
| Mar 31, 2023 | 104.00 Mn |
| Dec 31, 2022 | 104.10 Mn |
| Sep 30, 2022 | 104.00 Mn |
| Jun 30, 2022 | 103.90 Mn |
| Mar 31, 2022 | 102.90 Mn |
| Dec 31, 2021 | 100.50 Mn |
| Jun 30, 2019 | 8.97 Mn |
| Mar 31, 2019 | 11.39 Mn |
| Dec 31, 2018 | 11.30 Mn |
| Sep 30, 2018 | 14.20 Mn |
| Jun 30, 2018 | 38.00 Mn |
| Mar 31, 2018 | 43.65 Mn |
| Dec 31, 2017 | 52.75 Mn |